Openbookopenbook
Equity
GDRX
+0.0 · +0.00%
USD · NASDAQ

Goodrx Holdings Inc(GDRX) Stock Analysis | Healthcare

USD --+0.00%
Reward69High
Risk60Medium-High
75%Data
Thin 2% profit margin
Deep Value
Market Cap:1.18Bn
ⓘ
Reward Rating
69
High
Reward Assessment
75% data coverage
Top 25% of stocksView factors
ⓘ
Risk Rating
60
Medium-High
Risk Assessment
3 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on GDRX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for GDRX, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $4.03.

What is Goodrx Holdings Inc?

, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

GDRX · Verdict

Solid reward · elevated risk

GDRX stands out on valuation and cash flow, but watch the volatility signal.

Based on 88% data coverage

GDRX · Verdict

What’s working & what to watch

Strengths 4

  • Valuation100/100

    P/E 5.4× · PEG 0.31

  • Cash flow80/100

    21% free-cash-flow margin

  • Growth70/100

    Revenue +1.3% CAGR

  • Profitability66/100

    4% net margin · 3% ROE

Watchouts 1

  • Volatility20/100

    Weak vs peers

Model-based scoring. For information only — not financial advice.

What is Goodrx Holdings Inc?

, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.18B, and a P/E ratio of 57.5x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Moderate volatility with meaningful macro and earnings sensitivity.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (69)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Health Information Services names that are close enough in size to make side-by-side comparison useful.

TDOCSmall Cap / 1.2B market cap
Teladoc Inc
Compare
CERTSmall Cap / 1.3B market cap
Certara Inc
Compare
SDGRSmall Cap / 1.3B market cap
Schrodinger Inc
Compare
Company Information
SectorHealthcare
IndustryHealth Information Services
Market Cap1.18B
P/E Ratio57.5
Dividend YieldN/A
Beta1.58
Insider Activity
12M windowQuiet
Fewer than three real open-market insider trades in the last 12 months. Mechanical activity (option exercises, RSU vests) is excluded from the signal.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.